These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1367039)
21. B cell maturation factor (BMF): a lymphokine or family of lymphokines promoting the maturation of B lymphocytes. Sidman CL; Paige CJ; Schreier MH J Immunol; 1984 Jan; 132(1):209-22. PubMed ID: 6606666 [TBL] [Abstract][Full Text] [Related]
22. Partial purification and characterization of the human lymphocyte colony enhancing factor (LCEF). Zeevi A; Goldman I; Rozenszajn LA Immunology; 1978 Mar; 34(3):523-31. PubMed ID: 305893 [TBL] [Abstract][Full Text] [Related]
23. Biochemical characterization and purification of human B cell stimulatory factor (BSF). Schwarting R; Welte K; Chiorazzi N; Ralph P; Lane CL; Long C; Wang CY Eur J Immunol; 1985 Jun; 15(6):632-7. PubMed ID: 3874076 [TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. Yoshizaki K; Nakagawa T; Fukunaga K; Tseng LT; Yamamura Y; Kishimoto T J Immunol; 1984 Jun; 132(6):2948-54. PubMed ID: 6202767 [TBL] [Abstract][Full Text] [Related]
25. Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma. Margolick JB; Ambrus JL; Volkman DJ; Fauci AS J Immunol; 1986 Jan; 136(2):546-54. PubMed ID: 2416812 [TBL] [Abstract][Full Text] [Related]
26. Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. Grabstein K; Eisenman J; Mochizuki D; Shanebeck K; Conlon P; Hopp T; March C; Gillis S J Exp Med; 1986 Jun; 163(6):1405-14. PubMed ID: 3086481 [TBL] [Abstract][Full Text] [Related]
27. Inhibition or augmentation of PHA-induced lymphocyte transformation by factors of calculated lymphoblastoid cell lines. Pinto M; Mizrahi A Experientia; 1979 Apr; 35(4):544-6. PubMed ID: 312212 [TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. Gillis S; Smith KA; Watson J J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. Smith CA; Rennick DM Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1857-61. PubMed ID: 2937061 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes. Kerr MA; Hussein YM; Potts RC; Beck JS; Sheriff MM Immunology; 1987 Jun; 61(2):117-23. PubMed ID: 3596636 [TBL] [Abstract][Full Text] [Related]
31. Latent lymphokines: isolation of guinea pig latent lymphocyte-derived chemotactic factor for monocytes. Its activation by trypsin and a soluble factor from macrophages. Postlethwaite AE; Kang AH J Immunol; 1979 Aug; 123(2):561-7. PubMed ID: 458146 [TBL] [Abstract][Full Text] [Related]
32. Human growth factor for murine interleukin (IL)-9 responsive T cell lines: co-induction with IL-6 in fibroblasts and identification as LIF/HILDA. Van Damme J; Uyttenhove C; Houssiau F; Put W; Proost P; Van Snick J Eur J Immunol; 1992 Nov; 22(11):2801-8. PubMed ID: 1425908 [TBL] [Abstract][Full Text] [Related]
33. [Effect of lymphokines produced by human T-T hybridomas on the proliferation of normal and neoplastic B lymphocytes]. Gambatesa V Medicina (Firenze); 1989; 9(2):184-7. PubMed ID: 2811645 [TBL] [Abstract][Full Text] [Related]
34. [Regenerating hematopoietic tissue as a source for a low molecular weight factor that inhibits leukemic cell proliferation]. Sheleg SV; SvirnovskiÄ AI Biokhimiia; 1996 Apr; 61(4):621-8. PubMed ID: 8724783 [TBL] [Abstract][Full Text] [Related]
35. Characterization of an immune suppressor from transformed human trophoblastic JEG-3 cells. Wolf RL; Ilekis J; Benveniste R Cell Immunol; 1983 Jun; 78(2):356-67. PubMed ID: 6683129 [TBL] [Abstract][Full Text] [Related]
36. Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors. Butler JL; Falkoff RJ; Fauci AS Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2475-8. PubMed ID: 6609362 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a B cell-derived growth-enhancing factor produced by a human B cell line established from a patient with rheumatoid arthritis. Kang H; Koyasu S; Takei M; Tomura K; Karasaki M; Yahara I; Sawada S J Immunol; 1987 Aug; 139(4):1154-60. PubMed ID: 3497197 [TBL] [Abstract][Full Text] [Related]
38. Purification and partial characterization of human intracellular B cell growth factor. Sahasrabuddhe CG; Martin B; Maizel AL Lymphokine Res; 1986; 5(2):127-40. PubMed ID: 3486330 [TBL] [Abstract][Full Text] [Related]